Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of HER2 positive cancers

Treatment of HER2 positive cancers

US Patent 11207324 · Granted Dec 28, 2021

Estimated economic value: $242,683,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gut microbiota and treatment of cancer2025
Treatment of HER2 positive cancers2024
Treatment of HER2 positive cancers2024
Treatment of HER2 positive cancers2023
Treatment of HER2 positive cancers2023
Gut microbiota and treatment of cancer2023
Anti-TIGIT antibodies2022
Expanding panel and method of manufacture2019
Panel fixing assembly2018
MUC1 based glycolipopeptide vaccine with adjuvant2014
MUC1 based glycolipopeptide vaccine with adjuvant2012
Multi-component epoxy-amine primer systems comprising a polythioether2009